A study referencing afamelanotide was published on July 10, 2026, in the Journal of Controlled Release, the official journal of the Controlled Release Society. The publication is titled "Heterochiral co-assembly of β-strands and hairpins affords stereocomplexed peptide hydrogels for drug delivery."
The article was indexed under PubMed ID 41999898. It appears as a new entry in the scientific literature covering peptide hydrogel systems for drug delivery applications.
No results, efficacy data, or safety findings related to afamelanotide were included in the information provided about this publication. The listing reflects only that the study has been published and is now available through the journal and PubMed.
Readers interested in afamelanotide's regulatory status and general background can consult the compound overview for further context.